XRAY DENTSPLY SIRONA Inc.

MIXED Impact: 5/10 PRESS-RELEASE
Horizon immediate Filed May 5, 2026 Processed 1mo ago Wire GlobeNewswire
Press release: earnings
Latest settled — T+20d ⚠ clustered
XRAY ▼ -13.46% at T+20d
NEUTRAL call ✗ call lost -13.46% · α vs SPY -16.25% · entry $11.14 → $9.64
Next anchor: T+60d in 6w
Last close $10.09 (close Jun 12) · -9.43% from $11.14 entry
Entry anchored
May 5, 03:59 PM ET
via Databento tick
T+1d
0.00%
call 0.00% · α +0.33%
$11.14
settled 6w ago
T+5d
-1.26%
call -1.26% · α -2.39%
$11.00
settled 5w ago
T+20d
-13.46%
call -13.46% · α -16.25%
$9.64
settled 12d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

Dentsply Sirona reported Q1 2026 revenue of $880M, beating consensus of $840.1M by 4.7%, while adjusted EPS of $0.27 matched consensus. However, constant currency sales declined 6.7% YoY, adjusted EPS fell 39% YoY, and GAAP net loss was ($0.05)/share. The company reiterated its 2026 outlook, signaling confidence despite near-term headwinds. The mixed results reflect execution of its Return-to-Growth plan amid external pressures.

Key Financial Metrics

Guidance
$3.5 billion to $3.6 billion
maintained
Free Cash Flow
-$12.0M
Gross Margin
48.5%

Actionable Insight

Revenue beat and maintained guidance provide near-term support, but organic sales decline and margin compression signal underlying weakness. Watch for commentary on demand trends and restructuring execution on the earnings call for direction.

Key Facts

  • Revenue $880M vs consensus $840.1M (beat by 4.7%)
  • Adjusted EPS $0.27 in line with consensus, down 39% YoY from $0.44
  • GAAP net loss per share ($0.05) vs income $0.10 in prior year
  • Constant currency sales declined 6.7% YoY
  • Adjusted EBITDA margin fell to 14.7% from 19.0%
  • Maintained 2026 guidance: net sales $3.5B-$3.6B, adjusted EPS $1.40-$1.50
  • Operating cash flow improved to $40M vs $7M, free cash flow negative ($12M)

Financial Impact

Revenue beat of $39.9M but adjusted EPS down 39% YoY with organic sales decline of 6.7%

revenueepsmarginscash flow

Risk Factors

  • Continued organic revenue decline and market share loss
  • Restructuring execution risks and cost headwinds
  • Debt level of $2.2B with elevated interest expense

Market Snapshot

Exchange
Nasdaq
Sector
Dental Equipment & Supplies
Analyst Consensus
36% bullish (22 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3288198
7 reports for XRAY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XRAY — sortable, filterable
Type Now
Jun 11, 2026
3d ago
8-K
NEUTRAL ★ 3/10
$10.04 awaiting T+20awaiting T+20$10.09 (+0.50%)
May 5, 2026
5w ago
8-K
BEARISH ★ 6/10
$11.14 $9.64▲ +13.46%▲ +16.25%$10.09 (+9.43%)
May 5, 2026
5w ago
Press Release
MIXED ★ 5/10
$11.14 $9.64▼ −13.46%▼ −16.25%$10.09 (−9.43%)
Apr 22, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$11.90 $9.84▼ −17.31%▼ −21.95%$10.09 (−15.21%)
Mar 9, 2026
13w ago
Press Release
BULLISH ★ 7/10
$12.80 $11.52▼ −10.00%▼ −7.19%$10.09 (−21.17%)
Mar 3, 2026
14w ago
Insider Cluster
NEUTRAL ★ 4/10
$13.30 $11.60▼ −12.78%▼ −8.38%$10.09 (−24.14%)
Feb 24, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$12.80 $11.68▼ −8.75%▼ −3.51%$10.09 (−21.17%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 1h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access